K. Kissel

489 total citations
7 papers, 379 citations indexed

About

K. Kissel is a scholar working on Rheumatology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, K. Kissel has authored 7 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Rheumatology, 4 papers in Genetics and 2 papers in Pathology and Forensic Medicine. Recurrent topics in K. Kissel's work include Rheumatoid Arthritis Research and Therapies (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Systemic Lupus Erythematosus Research (2 papers). K. Kissel is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Systemic Lupus Erythematosus Research (2 papers). K. Kissel collaborates with scholars based in Germany, United Kingdom and Spain. K. Kissel's co-authors include Howard Amital, T. Huizinga, Philip G. Conaghan, Corrado Bernasconi, Maxime Dougados, Emilio Martín Mola, Georg Schett, Paul P. Tak, F. Navarro-Sarabia and Tom Sheeran and has published in prestigious journals such as Annals of the Rheumatic Diseases, International Urology and Nephrology and International Journal of Rheumatic Diseases.

In The Last Decade

K. Kissel

7 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K. Kissel Germany	6	335	181	103	94	49	7	379
E. Keystone Canada	8	259 0.8×	108 0.6×	86 0.8×	59 0.6×	70 1.4×	26	357
Jeffrey Box United States	3	336 1.0×	177 1.0×	137 1.3×	112 1.2×	58 1.2×	5	445
Minodora Mazur Moldova	6	279 0.8×	92 0.5×	113 1.1×	91 1.0×	52 1.1×	20	368
M. Robles Spain	4	315 0.9×	131 0.7×	81 0.8×	102 1.1×	87 1.8×	4	378
Hjalmar Wadström Sweden	6	230 0.7×	56 0.3×	81 0.8×	88 0.9×	121 2.5×	9	340
Masayuki Inoo Japan	5	144 0.4×	52 0.3×	36 0.3×	69 0.7×	68 1.4×	13	219
D. Schlichting United States	9	205 0.6×	92 0.5×	158 1.5×	65 0.7×	42 0.9×	27	371
Timothy Gathany United States	7	273 0.8×	129 0.7×	105 1.0×	34 0.4×	16 0.3×	13	312
Kurt Oelke United States	6	210 0.6×	61 0.3×	218 2.1×	41 0.4×	28 0.6×	7	377
J Biggs Australia	5	60 0.2×	171 0.9×	98 1.0×	54 0.6×	114 2.3×	5	309

Countries citing papers authored by K. Kissel

Since Specialization

Citations

This map shows the geographic impact of K. Kissel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Kissel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Kissel more than expected).

Fields of papers citing papers by K. Kissel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Kissel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Kissel. The network helps show where K. Kissel may publish in the future.

Co-authorship network of co-authors of K. Kissel

This figure shows the co-authorship network connecting the top 25 collaborators of K. Kissel. A scholar is included among the top collaborators of K. Kissel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Kissel. K. Kissel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Dougados, Maxime, K. Kissel, Philip G. Conaghan, et al.. (2014). Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study. Annals of the Rheumatic Diseases. 73(5). 803–809. 112 indexed citations

Dougados, Maxime, K. Kissel, Philip G. Conaghan, et al.. (2012). Clinical, Radiographic, and Immunogenic Effects After 1 Year of Tocilizumab-Based Treatment Strategy with and without Methotrexate in Rheumatoid Arthritis: The ACT-RAY Study. Data Archiving and Networked Services (DANS). 64(10). 6 indexed citations

Dougados, Maxime, K. Kissel, Tom Sheeran, et al.. (2012). Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY). Annals of the Rheumatic Diseases. 72(1). 43–50. 231 indexed citations

Dougados, Maxime, K. Kissel, Philip G. Conaghan, et al.. (2012). THU0093 Clinical, radiographic, and immunogenic effects after 1 year of tocilizumab (TCZ)-based treatment strategy with and without methotrexate (MTX) in RA: The act-ray study. Annals of the Rheumatic Diseases. 71. 185–185. 7 indexed citations

Dougados, Maxime, K. Kissel, Howard Amital, et al.. (2011). Double-Blind Study of Tocilizumab Plus Methotrexate Vs Tocilizumab Plus Placebo in Patients with Active Rheumatoid Arthritis Despite Prior Methotrexate : Progression of Structural Damage, Quality of Life, and Physical Function At 24 Weeks.. Data Archiving and Networked Services (DANS). 63(10). 28–29. 6 indexed citations

Vollenhoven, Ronald van, et al.. (2010). 2.4. Rheumatoid arthritis ‐ non‐TNFα biological therapies. International Journal of Rheumatic Diseases. 13(s1). 95–105. 1 indexed citations

Takashi, M., Ulrich Schenck, K. Kissel, H. Leyh, & Uwe Treiber. (1999). Use of Diagnostic Categories in Urinary Cytology in Comparison with the Bladder Tumour Antigen (BTA) Test in Bladder Cancer Patients. International Urology and Nephrology. 31(2). 189–196. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact